EANM’08 – CME Session VIII
Therapy / Dosimetry
October 13, 2008, 16:30 – 18:00
Dosimetry for the Treatment of Bony Metastases with Radionuclide Therapy
Moderator: G. Flux (London)
Co-Moderator: L. Bodei (Milan)
- Identify and use guidelines relevant for the treatment of bony metastases.
- Identify new options, with advantages and disadvantages, for treating bony metastases.
- Understand the potential for moving towards metastatic tumour control from palliation.
- Identify dosimetry methodology for the treatment of bone metastases.
- Understand arguments for pursuing improved treatments using new radionuclides and dosimetry.
This continuing education session is directed primarily towards physicians and physicists concerned with the treatment of bony metastases with radiopharmaceuticals. The advantages and disadvantages of standard methods of treatment will be examined and new EANM guidelines concerning these will be presented. The session will focus on new treatment options, particularly the use of alpha emitters, and their potential to offer metastatic control as well as palliation. Theoretical and practical aspects will be detailed. The possibilities of imaging and performing patient-specific dosimetry for these radionuclides will be discussed in detail.
Targeted radionuclide therapy, bony metastases, dosimetry, guidelines